Abstract
M alignant hyperthermia (MH) is an inherited ,disorder characterized by a hypermetabolic response to succinylcholine and/or potent volatile anesthetic agents (Table 1). It is inherited in humans as an autosomal dominant trait. MH-susceptible patients usually do not have symptoms or signs of problems other than during administration of anesthesia. As such, MH is a prototypical pharmacogenetic disorder, and the only disease of anesthesia. Because an MH crisis may occur wherever and whenever trigger-volatile agents are administered, it is appropriate to be prepared to diagnose and manage an MH crisis wherever general anesthesia is administered, be it a hospital, officg, or ambulatory center. The goal of this article is to provide the most recent information concerning prevention, diagnosis, treatment, and management of MH in the ambulatory setting. The article will address questions associated with managing MH-susceptible patients in a free-standing surgery center as well as a physician's office.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Seminars in Anesthesia, Perioperative Medicine and Pain
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
